MGI Pharma MOGN New patents, anti cancer Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MGI Pharma MOGN New patents, anti cancer

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (156)	9/11/1997 5:57:00 PM
From: David Cathcart	of 1826

Rick I'm not in your league when it comes to analyzing companies. There...I've said it. : - ) Look at my profile and you will see that I was a philosophy major. I work at analyzing companies but there are others who are better qualified. What I do is try to digest what the experts say and combine that with my own research and observations. From your post yesterday, I thought you were anticipating a price for MOGN in the $7 - 8 range based primarily on Salagen alone. If this stock breaks through $6, investors are going to begin to look at it in a different way. Once they look closer at Salagen, they will see INFeD, they will see MGI 114 (and perhaps even assign a value to a potentially blockbuster cancer drug!!!!), and yes they will see good management. It is a novel thought, but MGI Pharma may actually experience the benefit of a little upside momentum. Once it breaks through the sixish barrier, where it settles is a big question and one you are better qualified to answer. If it has the momentum to push through $6, why will it stop at $8? One last question...Who the #%* is Henry? : - ) David

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next